Therapeutic angiogenesis for peripheral artery disease: Cytokine therapy

Vasa - Journal of Vascular Diseases

Volumn 36, Issue 4, 2007, Pages 253-260

  Kuhlmann, M T ^a   Klocke, R ^a   Nikol, Sigrid ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Bone marrow mobilisation; Bone marrow mononuclear cell; Endothelial progenitor cell; Granulocyte colony stimulating factor; Granulocyte macrophage colony stimulating factor; Peripheral artery disease; Therapeutic angiogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLONY STIMULATING FACTOR; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; SCATTER FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ANGIOGENESIS; ARTERY DISEASE; BONE MARROW CELL; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMORAL ARTERY; HEMATOPOIETIC STEM CELL; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; LIMB PERFUSION; MESENCHYMAL STEM CELL; MONOCYTE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT DURATION;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BONE MARROW CELLS; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HINDLIMB; HUMANS; ISCHEMIA; LEG; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 37149054320     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.36.4.253     Document Type: Review

References (56)

1. Arai M, Misao Y, Nagai H, Kawasaki M, Nagashima K, Suzuki K, et al. Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral artery disease. Circ J 2006 Sep; 70(9): 1093-8.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 Feb 14; 275(5302): 964-7.
3. Berliner N, Hsing A, Graubert T, Sigurdsson F, Zain M, Bruno E, et al. Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood 1995 Feb 1; 85(3): 799-803.
4. Boccalon H, Lehert P, Mosnier M. [Assessment of the prevalence of atherosclerotic lower limb arteriopathy in France as a systolic index in a vascular risk population]. J Mal Vasc 2000 Feb; 25(1): 38-46.
5. Buschmann IR, Hoefer IE, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, et al. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 2001 Dec; 159(2): 343-56.
6. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989 Feb 2; 337(6206): 471-3.
7. Bussolino F, Ziehe M, Wang JM, Alessi D, Morbidelli L, Cremona O, et al. In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J Clin Invest 1991 Mar; 87(3): 986-95.
8. Caplice NM, Doyle B. Vascular progenitor cells: origin and mechanisms of mobilization, differentiation, integration, and vasculogenesis. Stem Cells Dev 2005 Apr; 14(2): 122-39.
9. Capoccia BJ, Shepherd RM, Link DC. G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 2006 Oct 1; 108(7): 2438-45.
10. Chen X, Kelemen SE, Autieri MV. AIF-1 expression modulates proliferation of human vascular smooth muscle cells by autocrine expression of G-CSF. Arterioscler Thromb Vasc Biol 2004 Jul; 24(7): 1217-22.
11. Chen X, Kelemen SE, Autieri MV. Expression of granulocyte colony-stimulating factor is induced in injured rat carotid arteries and mediates vascular smooth muscle cell migration. Am J Physiol Cell Physiol 2005 Jan; 288(1): C81-8.
12. Cox G, Gauldie J, Jordana M. Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am J Respir Cell Mol Biol 1992 Nov; 7(5): 507-13.
13. Deindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, et al. G-CSF administration after myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. Faseb J 2006 May; 20(7): 956-8.
14. Dick P, Mlekusch W, Sabeti S, Amighi J, Schlager O, Haumer M, et al. Outcome after endovascular treatment of deep femoral artery stenosis: results in a consecutive patient series and systematic review of the literature. J Endovasc Ther 2006 Apr; 13(2): 221-8.
15. Diehm C, Schuster A, Allenberg JR, Darius H, Haberl R, Lange S, et al. High prevalence of peripheral arterial disease and comorbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 2004 Jan; 172(1): 95-105.
16. Dong F, Larner AC. Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood 2000 Mar 1; 95(5): 1656-62.
17. Fujii K, Ishimaru F, Kozuka T, Matsuo K, Nakase K, Kataoka I, et al. Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br J Haematol 2004 Jan; 124(2): 190-4.
18. Garcia LA. Epidemiology and pathophysiology of lower extremity peripheral arterial disease. J Endovasc Ther 2006 Feb; 13 Suppl 2: II3-9.
19. Gokce N, Vita JA, Bader DS, Sherman DL, Hunter LM, Holbrook M, et al. Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol 2002 Jul 15; 90(2): 124-7.
20. Grundmann S, Hoefer I, Ulusans S, Bode C, Oesterle S, Tijssen JG, et al. Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps. J Vasc Surg 2006 Jun; 43(6): 1263-9.
21. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 2005 Mar; 11(3): 305-11.
22. Heil M, Eitenmuller I, Schmitz-Rixen T, Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 2006 Jan-Mar; 10(1): 45-55.
23. Heil M, Schaper W. Cellular mechanisms of arteriogenesis. Exs 2005(94): 181-91.
24. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, et al. Blood monocyte concentration is critical for enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 2002 Dec; 283(6): H2411-9.
25. Heil M, Ziegelhoeffer T, Wagner S, Fernandez B, Helisch A, Martin S, et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 2004 Mar 19; 94(5): 671-7.
26. Hoefer IE, van Royen N, Buschmann IR, Piek JJ, Schaper W. Time course of arteriogenesis following femoral artery occlusion in the rabbit. Cardiovasc Res 2001 Feb 16; 49(3): 609-17.
27. Hoogeveen RC, Morrison A, Boerwinkle E, Miles JS, Rhodes CE, Sharrett AR, et al. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. Atherosclerosis 2005 Dec; 183(2): 301-7.
28. Ieda Y, Fujita J, Ieda M, Yagi T, Kawada H, Ando K, et al. G-CSF and HGF: Combination of vasculogenesis and angiogenesis synergistically improves recovery in murine hind limb ischemia. J Mol Cell Cardiol 2007 Mar; 42(3): 540-8.
29. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997 Jun; 80(6): 829-37.
30. Jeon O, Hwang KC, Yoo KJ, Kim BS. Combined sustained delivery of basic fibroblast growth factor and administration of granulocyte colony-stimulating factor: synergistic effect on angiogenesis in mouse ischemic limbs. J Endovasc Ther 2006 Apr; 13(2): 175-81.
31. Kaushansky K, Lin N, Adamson JW. Interleukin 1 stimulates fibroblasts to synthesize granulocyte-macrophage and granulocyte colony-stimulating factors. Mechanism for the hematopoietic response to inflammation. J Clin Invest 1988 Jan; 81(1): 92-7.
32. Kim CK, Schmalfuss CM, Schofield RS, Sheps DS. Pharmacological treatment of patients with peripheral arterial disease. Drugs 2003; 63(7): 637-47.
33. Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004 Mar 19; 94(5): 678-85.
34. Koeffler HP, Gasson J, Ranyard J, Souza L, Shepard M, Munker R. Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor. Blood 1987 Jul; 70(1): 55-9.
35. Kuhlmann MT, Kirchhof P, Klocke R, Hasib L, Stypmann J, Fabritz L, et al. G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis. J Exp Med 2006 Jan 9; 203(1): 87-97.
36. Lachmann N, Nikol S. Therapeutic angiogenesis for peripheral artery disease - Stem cell therapy. Vasa 2007; 36: 241-251.
37. Lee M, Aoki M, Kondo T, Kobayashi K, Okumura K, Komori K, et al. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor. Arterioscler Thromb Vasc Biol 2005 Dec; 25(12): 2535-41.
38. Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001 Sep; 86(3): 262-4.
39. Minamino K, Adachi Y, Okigaki M, Ito H, Togawa Y, Fujita K, et al. Macrophage colony-stimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells 2005 Mar; 23(3): 347-54.
40. Nikol S. Therapeutic angiogenesis for peripheral artery disease - Gene therapy. Vasa 2008; 37: (in press).
41. O'Neill TJ, Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 2005 Nov 11; 97(10): 1027-35.
42. Ohki Y, Heissig B, Sato Y, Akiyama H, Zhu Z, Hicklin DJ, et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. Faseb J 2005 Dec; 19(14): 2005-7.
43. Ohmi C, Matsuyama H, Tei Y, Yoshihiro S, Shimabukuro T, Ohmoto Y, et al. Granulocyte colony-stimulating factor may promote proliferation of human bladder cancer cells mediated by basic fibroblast growth factor. Scand J Urol Nephrol 2003; 37(4): 286-91.
44. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007 Feb 6; 115(5): e69-171.
45. Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 2001 Oct 23; 104(17): 2012-7.
46. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989 Oct 14; 2(8668): 891-5.
47. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary. Circulation. 2000 Sep 12; 102(11): E73-86.
48. Takagi Y, Omura T, Yoshiyama M, Matsumoto R, Enomoto S, Kusuyama T, et al. Granulocyte-colony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia. J Pharmacol Sci 2005 Sep; 99(1): 45-51.
49. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005 Nov; 39(5): 733-42.
50. van Royen N, Schirmer SH, Atasever B, Behrens CY, Ubbink D, Buschmann EE, et al. START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation 2005 Aug 16; 112(7): 1040-6.
51. Vellenga E, Rambaldi A, Ernst TJ, Ostapovicz D, Griffin JD. Independent regulation of M-CSF and G-CSF gene expression in human monocytes. Blood 1988 Jun; 71(6): 1529-32.
52. Voskuil M, Hoefer IE, van Royen N, Hua J, de Graaf S, Bode C, et al. Abnormal monocyte recruitment and collateral artery formation in monocyte chemoattractant protein-1 deficient mice. Vasc Med 2004 Nov; 9(4): 287-92.
53. Voskuil M, van Royen N, Hoefer IE, Seidler R, Guth BD, Bode C, et al. Modulation of collateral artery growth in a porcine hindlimb ligation model using MCP-1. Am J Physiol Heart Circ Physiol 2003 Apr; 284(4): H1422-8.
54. Wiesinger B, Heller S, Schmehl J, Claussen CD, Wiskirchen J, Tepe G. Percutaneous vascular interventions in the superficial femoral artery. A review. Minerva Cardioangiol 2006 Feb; 54(1): 83-93.
55. Ziegelhoeffer T, Fernandez B, Kostin S, Heil M, Voswinckel R, Helisch A, et al. Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ Res 2004 Feb 6; 94(2): 230-8.
56. Zsebo KM, Yuschenkoff VN, Schiffer S, Chang D, McCall E, Dinarello CA, et al. Vascular endothelial cells and granulopoiesis: interleukin-1 stimulates release of G-CSF and GM-CSF. Blood 1988 Jan; 71(1): 99-103.